This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sasaki, S. Articles by Bunag, R. D. Search for Related Content PubMed PubMed Citation Articles by Sasaki, S. Articles by Bunag, R. D.

Hypertension, Vol 5, 34-40, Copyright © 1983 by American Heart Association

ARTICLES

Insulin reverses hypertension and hypothalamic depression in streptozotocin diabetic rats

S Sasaki and RD Bunag

Daily subcutaneous injections of lente insulin reduced the hypertension and bradycardia which developed consistently in streptozotocin diabetic rats. Insulin-treated rats also became less hyperglycemic, drank less water, and gained weight faster than untreated diabetic controls. Behavioral and tachycardiac effects elicited by electrical stimulation of the ventromedial hypothalamus while the rats were awake were similar, but attendant pressor responses were larger in those that had been treated with insulin. Under subsequent urethane anesthesia, pressor and sympathetic responses to hypothalamic stimulation, as well as pressor responses to tyramine and vasopressin, were augmented in insulin-treated rats. A generalized increase in cardiovascular reactivity caused by insulin seemed unlikely since pressor responses to norepinephrine were unaltered. Enhanced hypothalamic responsiveness was considered due to improvement of diabetic encephalopathy rather than to direct CNS stimulation by insulin because the injected insulin had mostly dissipated by the time pressor responses were recorded. By showing that insulin treatment produced changes opposite to those occurring during induction of diabetes our results suggest that insulin can alleviate cardiovascular and hypothalamic dysfunction in streptozotocin-induced diabetes.

This article has been cited by other articles:

				K. Bedard, J. Strecko, K. Theriault, J. Bedard, C. Veyrat-Durebex, and P. Gaudreau Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E740 - E751. [Abstract] [Full Text] [PDF]

				Y.-J. Liu, Y. Nakagawa, and T. Ohzeki Gene Expression of 11ß-Hydroxysteroid Dehydrogenase Type 1 and Type 2 in the Kidneys of Insulin-Dependent Diabetic Rats Hypertension, March 1, 1998; 31(3): 885 - 889. [Abstract] [Full Text] [PDF]

				M. W. Brands and T. E. Hopkins Poor Glycemic Control Induces Hypertension in Diabetes Mellitus Hypertension, March 1, 1996; 27(3): 735 - 739. [Abstract] [Full Text]

				C.Y. Maeda, T.G. Fernandes, H.B. Timm, and M.C. Irigoyen Autonomic Dysfunction in Short-term Experimental Diabetes Hypertension, December 1, 1995; 26(6): 1100 - 1104. [Abstract] [Full Text]

				Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders Ann Intern Med, November 1, 1986; 105(5): 714 - 729. [Abstract] [PDF]